Crdentia Announces Intent to Acquire iVOW, Inc.

Company Terminates Previously Announced Non-Binding Letter of Intent to Merge With Caregiver Services Inc. 


DALLAS, Sept. 6  /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC:CRDT) (BULLETIN BOARD: CRDT) , a leading U.S. provider of healthcare staffing services, today announced that it has signed a non-binding term sheet to acquire iVOW, Inc. (NASDAQ:IVOW), a provider of disease management services for the treatment of chronic and morbid obesity.  If the transaction is completed, Crdentia intends to operate and develop iVOW's leading programs for the medical and surgical management of chronic and morbid obesity.  Pursuant to the term sheet, Crdentia would acquire all outstanding shares of iVOW for approximately $3.5 million in Crdentia common shares, subject to adjustment based on iVOW's debt and accounts receivable at closing.  Crdentia anticipates that the acquisition of iVOW will facilitate the receipt of a NASDAQ Capital Market listing for the combined company.  The completion of the transaction is subject to negotiation and execution of a definitive agreement.  Any potential closing would occur in the fourth quarter after receipt of the requisite stockholder approvals.  The term sheet requires iVOW to preserve its assets, and to have a minimum cash balance upon signing of the definitive agreement. The combined companies will be a leading provider of healthcare staffing services along with the medically-validated management of chronic and morbid obesity to large corporate clients and their employees.

Concurrently, Crdentia also disclosed today that it has discontinued negotiations under the previously announced non-binding letter of intent to merge with Caregiver Services, Inc.

About Crdentia Corp.

Crdentia Corp. is one of the nation's leading providers of healthcare staffing services.  Crdentia seeks to capitalize on an opportunity that currently exists in the healthcare industry by targeting the critical nursing and allied shortage issue.  There are many small, private companies that are addressing the rapidly expanding needs of the healthcare industry. Unfortunately, due to their relatively small capitalization, they are unable to maximize their potential, obtain outside capital or expand.  By consolidating well-run small private companies into a larger public entity, Crdentia intends to facilitate access to capital, the acquisition of technology, providing greater diversity of client services and expanded distribution that, in turn, drive internal growth.  For more information, visit http://www.crdentia.com/.

About iVOW, Inc.

Our business is focused exclusively on the disease state management of chronic and morbid obesity. We provide program management, operational consulting and clinical training services to physicians and hospitals involved in the medical and surgical treatment of morbidly obese patients.  We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is http://www.ivow.com/; information on our nutritional supplements for post-surgical gastric bypass patients may be found on http://www.vistavitamins.com/.  iVOW is the new corporate name of Vista Medical Technologies, Inc.  iVOW is traded on the NASDAQ Capital Market under the stock symbol IVOW.

Forward Looking Statements

Statements contained in this release that are not historical facts are forward-looking statements that involve risks and uncertainties.  Among the important factors which could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, failure to execute a definitive agreement with respect to the iVOW transaction and those discussed in "Risk Factors" in the Company's Forms 10-KSB, Forms 10-QSB, and other filings with the Securities and Exchange Commission.  Such risk factors include, but are not limited to, a limited operating history with no earnings; reliance on the Company's management team, members of which have other business interests; the ability to successfully implement the Company's business plan; the ability to continue as a going concern; the ability to fund the Company's business and acquisition strategy; the growth of the temporary healthcare professional staffing business; difficulty in managing operations of acquired businesses; uncertainty in government regulation of the healthcare industry; and the limited public market for the Company's common stock.  The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties.  We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

  AT THE COMPANY:                     AT FINANCIAL RELATIONS BOARD:
  James D. Durham                     Lasse Glassen
  Chairman and CEO                    310-854-8313
  972-850-0780                        

DATASOURCE: Crdentia Corp.



CONTACT:  James D. Durham, Chairman and CEO of Crdentia Corp.,

[phone]; or Lasse Glassen, [phone],

, for Crdentia Corp.



Web site:  http://www.ivow.com/ 

Web site:  http://www.vistavitamins.com/ 

Web site:  http://www.crdentia.com/ 

Copyright